Clinical Trials Logo
  1. Home
  2. Ulcer
  3. NCT03440528
  4. Details
NCT03440528 Clinical Trial

Using of Irradiated Amnion Dressing for the Treatment of Skin Ulcer

Ulcer Clinical Trial

Official title:
Using of Irradiated Amnion Dressing for the Treatment of Skin Ulcer

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03440528
Other study ID # 29112017NCRRT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 2, 2016
Est. completion date October 2018

Study information
Verified date September 2023
Source Egyptian Atomic Energy Authority
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate the using of a commercial product of dried human amniotic membrane sterilized by gamma irradiation for the treatment of skin ulcer.

Description:

Dried human amniotic membrane patches were obtained from National center for radiation research and technology, Egypt, under commercial name REGE pro.

Recruitment information / eligibility
Status Completed
Enrollment 3
Est. completion date October 2018
Est. primary completion date September 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients have unhealing ulcer Exclusion Criteria: - must stop other line of treatment

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Egypt Amniotic tissue lab Cairo

Sponsors (2)
Lead Sponsor Collaborator
Egyptian Atomic Energy Authority Waleed Nemr,Egyptian Atomic Energy Authority

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Other Complete curring REGE pro healed ulcer after 4 to 10 weeks. The improvement of ulcer was observed by photographs taken before and each week post application. 4 to 10 weeks
Other Freedom from scarring It was observed that the using of REGE pro prevent any scar formation in all applied patients. 10 weeks
Primary Size of ulcer REGE pro decreased size of ulcer after second treatment 2 week
Secondary Reduction of pain Patients response revealed reduction of pain at the time of application. One week post application, a questionnaire were collected from patients; about 95% of them ensured that pain was controlled. 1 week
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02565264 - Effect of Plasma Derived Exosomes on Cutaneous Wound Healing Early Phase 1
Completed NCT02838251 - Effects of Compression in Mixed Ulcers N/A
Recruiting NCT00926809 - H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection Phase 4
Completed NCT00633035 - Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit Phase 4
Completed NCT00402727 - Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection Phase 3
Completed NCT06464250 - The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients N/A
Not yet recruiting NCT03250533 - Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers N/A
Terminated NCT01657318 - Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Completed NCT02535481 - Epidermal Grafting in Wound Healing N/A
Withdrawn NCT01215058 - Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer N/A
Recruiting NCT04210089 - Total Contact Soft Cast in Diabetic Foot Ulcers N/A
Completed NCT04573959 - Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System N/A
Recruiting NCT03347812 - Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair N/A
Active, not recruiting NCT02973893 - Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Phase 2
Terminated NCT01853384 - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers Phase 3
Completed NCT00221143 - Stem Cell Study for Patients With Leg Ulcer/Gangrene Phase 1/Phase 2
Completed NCT00158483 - Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) Phase 2
Completed NCT00660049 - Feasibility Study of a Novel Device for Chronic Wounds N/A
Completed NCT00450216 - Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment Phase 3
Completed NCT00164424 - Episodic Acyclovir Therapy for Genital Ulcers Phase 2/Phase 3